News & Events

Calendar of Events

Upcoming seminar and event information

Dr. Roy Gulick leaning on desk in office

Weill Cornell Medicine has received a renewal of a prestigious ...

Read More
arm on couch with IV in hand

The COVID-19 pandemic will potentially lead to greater disparities in cancer care and outcomes among Black and Hispanic New Yorkers, according to a viewpoint article published in JAMA Oncology on Aug. 13 by Weill Cornell Medicine and NewYork-Presbyterian investigators. The authors write that higher rates of SARS-CoV-2 infection among Blacks and Hispanics will lead to delays...

Read More
Illustration of COVID-19 molecules and blood cells

A study by investigators at Weill Cornell Medicine and NewYork-Presbyterian aims to answer one of COVID-19’s biggest mysteries: why do some people become severely ill, while others have no symptoms? The multidisciplinary team will seek to identify underlying genetic and immune factors that contribute to these varying outcomes to help guide the development of precision prevention and treatment efforts.

The ...

Read More
Researcher looking at information on tablet in laboratory

With the need for wide scale COVID-19 testing to allow societies reopen safely, a group from Weill Cornell Medicine and other academic medical centers and research organizations have announced the launch of a global competition for low-cost, high-quality and scalable COVID-19 tests, called the COVID-19 XPRIZE, in a ...

Read More
COVID-19 molecules

The amount of SARS-CoV-2 virus, or “viral load,” in cancer patients and in the general inpatient population upon hospital admission may predict their risk of dying of the infection, according to a study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian. The findings provide new insights into the relationship between viral load and the risk of severe illness in both populations and may help guide treatment decisions.

The researchers, whose ...

Read More
male physician testing older female blood pressure

New York, NY – NewYork Quality Care, the accountable care organization (ACO) of NewYork-Presbyterian, Columbia University Irving Medical Center, and Weill Cornell Medicine, saved Medicare $23,288,625 in 2019 and improved the quality of care for Medicare beneficiaries, according to performance results recently released by the Centers for Medicare & Medicaid Services (CMS). The three...

Read More
illustration of diversity

Drawing on New York’s diverse population, Weill Cornell Medicine scientists have been awarded grants from the New York Genome Center (NYGC) to study how several types of cancer differ in patients with different genetic backgrounds and point to precision treatments for groups that have been historically underrepresented in cancer research. 

Investigators at Weill Cornell Medicine are leading three of the six projects, which range from $150,000 and $370,000 in...

Read More
COVID-19 molecule

Cancer patients who contracted COVID-19 during the height of the pandemic in New York City had similar outcomes to other patients with COVID-19, a study from researchers at Weill Cornell Medicine and NewYork-Presbyterian has found. The findings suggest that in the absence of other risk factors for poor COVID-19 outcomes, patients with cancer may be able to safely continue treatment during the pandemic. It is important to weigh the risk of severe COVID-19 illness against the risk of delaying...

Read More
Medical stethoscope on a stack of paper.

Physicians who care for the most socially disadvantaged patients were more likely to receive lower scores in a Centers for Medicare & Medicaid Services (CMS) program that...

Read More
Dr. Brad Jones in laboratory

T-cells taken from the blood of people who recovered from a COVID-19 infection can be successfully multiplied in the lab and maintain the ability to effectively target proteins that are key to the virus’s...

Read More
COVID-19 molecule

Weill Cornell Medicine and NewYork-Presbyterian investigators have built a machine-learning tool that can predict SARS-CoV-2 infection based on age, gender, race and 27 routine laboratory test results. The innovation holds potential for identifying high-risk patients infected by the virus within two hours, much sooner than waiting 24 hours or longer for standard RT-PCR test results from nasal/throat swabs. Faster identification could allow physicians to isolate and treat infected patients...

Read More
Human pluripotent stem cell-derived alveolar organoid xenograft. Red: Pro-SP-B (an Alveolar Type 2 cell marker) and Green: ACE2 (a receptor of SARS-CoV-2)

Human organoids, tiny organ-like structures grown in...

Read More
Digital depiction of how COVID-19 affects neurons in the brain
Read More
The image illustrates three distinct structures uncovered across thousands of cancer genomes: a rift (rigma) in the wall, recurrent towers (pyrgo), and a dramatic tornado (typhoon) shape a complex and turbulent landscape.
...
Read More
illustration of COVID-19 molecule

The amount of SARS-CoV-2 virus, or “viral load,” in cancer patients and in the general inpatient population upon hospital admission may predict their risk of dying of the infection, according to a study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian. The findings provide new insights into the relationship between viral load and the risk of severe illness in both populations and may help guide treatment decisions.

The researchers, whose ...

Read More
hand with IV

The COVID-19 pandemic will potentially lead to greater disparities in cancer care and outcomes among Black and Hispanic New Yorkers, according to a viewpoint article published in JAMA Oncology on Aug. 13 by Weill Cornell Medicine and NewYork-Presbyterian investigators. The authors write that higher rates of SARS-CoV-2 infection among Blacks and Hispanics will lead to delays...

Read More
illustration of COVID-19 molecule

A study by investigators at Weill Cornell Medicine and NewYork-Presbyterian aims to answer one of COVID-19’s biggest mysteries: why do some people become severely ill, while others have no symptoms? The multidisciplinary team will seek to identify underlying genetic and immune factors that contribute to these varying outcomes to help guide the development of precision prevention and treatment efforts.

The ...

Read More
lab space with person holding tablet

With the need for wide scale COVID-19 testing to allow societies reopen safely, a group from Weill Cornell Medicine and other academic medical centers and research organizations have announced the launch of a global competition for low-cost, high-quality and scalable COVID-19 tests, called the COVID-19 XPRIZE, in a ...

Read More
illustration of COVID-19 molecule

Weill Cornell Medicine has awarded eight grants of $100,000 each to faculty for a variety of research projects on COVID-19, funded by the institution’s Board of Overseers and additional donors. The grants will support studies aimed at understanding fundamental aspects of the disease, the body’s immune response and social determinants of health that affect COVID-19 outcomes...

Read More
physician speaking to laptop using telehealth

Weill Cornell Medicine investigators have received a total of $3.5 million from the Patient-Centered Outcomes Research Institute (PCORI) to study the effectiveness of telehealth services during the COVID-19 pandemic, and to develop models that can aid in clinical decision making in the treatment of the virus.

...
Read More

Government & Community Affairs 1300 York Ave., Box 314 New York, NY 10065